Kura Oncology Inc (KURA)
10.80
+0.74
(+7.36%)
USD |
NASDAQ |
Nov 22, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Free Cash Flow: -169.24M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -169.24M |
| June 30, 2024 | -154.84M |
| March 31, 2024 | -138.01M |
| December 31, 2023 | -124.99M |
| September 30, 2023 | -117.21M |
| June 30, 2023 | -109.55M |
| March 31, 2023 | -114.37M |
| December 31, 2022 | -110.69M |
| September 30, 2022 | -107.61M |
| June 30, 2022 | -111.54M |
| March 31, 2022 | -109.38M |
| December 31, 2021 | -105.70M |
| September 30, 2021 | -100.81M |
| June 30, 2021 | -93.13M |
| March 31, 2021 | -80.22M |
| December 31, 2020 | -72.00M |
| September 30, 2020 | -67.35M |
| June 30, 2020 | -61.86M |
| Date | Value |
|---|---|
| March 31, 2020 | -60.84M |
| December 31, 2019 | -54.76M |
| September 30, 2019 | -51.04M |
| June 30, 2019 | -51.89M |
| March 31, 2019 | -50.06M |
| December 31, 2018 | -48.66M |
| September 30, 2018 | -45.92M |
| June 30, 2018 | -39.15M |
| March 31, 2018 | -32.67M |
| December 31, 2017 | -28.44M |
| September 30, 2017 | -27.70M |
| June 30, 2017 | -26.94M |
| March 31, 2017 | -26.66M |
| December 31, 2016 | -25.35M |
| September 30, 2016 | -24.23M |
| June 30, 2016 | -23.21M |
| March 31, 2016 | -21.17M |
| December 31, 2015 | -17.99M |
Free Cash Flow Range, Past 5 Years
-169.24M
Minimum
Sep 2024
-54.76M
Maximum
Dec 2019
-103.21M
Average
-108.50M
Median
Free Cash Flow Benchmarks
| Halozyme Therapeutics Inc | 392.71M |
| AIM ImmunoTech Inc | -21.33M |
| Perspective Therapeutics Inc | -40.58M |
| Protalix BioTherapeutics Inc | 7.171M |
| Armata Pharmaceuticals Inc | -42.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -43.44M |
| Cash from Investing (Quarterly) | 45.54M |
| Cash from Financing (Quarterly) | 2.202M |
| Free Cash Flow Per Share (Quarterly) | -0.4996 |
| Free Cash Flow Yield | -18.72% |